Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Joint gel injection after surgery shows promise in tiny trial

NCT ID NCT07468045

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether injecting hyaluronic acid into the knee or shoulder right after arthroscopic surgery helps with recovery and pain control. Nine adults aged 18 to 60 who had scheduled arthroscopy received the injection during their procedure. Researchers measured safety, range of motion, and pain scores over 24 weeks to see if the treatment improved outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
hyaluronic acid
What this could lead to
If it works, this could point toward a way to help people recover faster and with less pain after joint surgery.
What could go wrong
This was a very small study with only 9 people, so results may not apply to everyone. It also did not compare against a placebo, so benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

9 people

The number who actually took part.

Started

Oct 2024

Finished

Jul 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male and female adults aged 18 to 60 years at the date of the written informed consent form. 2. Patient with surgery scheduled for arthroscopic procedure on knee or shoulder. 3. Those who could understand the provided information and were able to fill out the questionnaire. 4. Those who voluntarily decided to participate in the study and wrote the informed consent form. Exclusion Criteria: 1. In the following cases that may affect test results 1. Patients with history and suspected of rheumatoid arthritis (RA). 2. Patients with osteoarthritis in the joint related to specific joint movement. 3. Those with a history of surgery in the related area of the join that affect join movement. 4. Patients with infection at the surgical site. 2. Patients with chronic diseases that may affect surgery, such as uncontrolled diabetes or uncontrolled high blood pressure. 3. Patients with complex regional pain syndrome. 4. If adverse reactions are expected during surgery in the following cases: 1. People taking blood coagulants or patients with diseases that require blood coagulants. 2. When there are restrictions on the use of anticoagulants or antithrombotic agents. 3. Those with confirmed severe liver dysfunction or decreased renal function. 4. Patients with other serious systemic diseases such as severe anemia. 5. Known HIV positive person receiving medication. 5. Patients are allergic to substances used in medical devices for the study (Hyaluronic Acid). 6. Pregnant, lactating, or women of childbearing potential who are unwilling to use contraception during the study. 7. Use of drugs or medical devices due to participation in other study 8. Other people deemed inappropriate to participate in the test by the investigator (including high probability of noncompliance).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arthroscopic surgery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • MRCCC Siloam Hospitals Semanggi

    Jakarta, 12930, Indonesia

  • Siloam Hospitals Mampang

    Jakarta, 12760, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.